and subsidiaries thus reported Baht 90,484 million in operating profit before provision expense and income tax expense, rising Baht 935 million, or 1.05 percent, over-year. The increase was derived from
increase financial liquidity for core businesses in which the Company has an expertise and in accordance with the Company’s policy, i.e. printing media, relevant events organization, television business and
valuation methodology assuming the construction has completed by estimating the business operation (revenue and expense) of the Company in the next 10 years and used the discounted cash flow method by
outsourced production with fully completed services, from formulation development, research, marketing and label design and packaging services, including cosmetic product filings with the Food and Drug
Manufacturer and supplier of cosmetic products by way of outsourced production with fully completed services, from formulation บริษัท ดีโอดี ไบโอเทค จ ำกัด (มหำชน) 111 หมู่ท่ี 2 ต ำบลท่ำจนี อ ำเภอเมืองสมุทรสำคร
the Company to enter into the transaction for asset divestment, the Company shall then commence the bidding process expecting that the divestment of assets shall be completed around March – April 2018
120,000,000 2.95 3. Approved the adjustment to increase the base price for divestment of some certain assets of the Company to be in accordance with the new assessment value as adjusted by the asset appraiser
31 December 2023 is the most recently completed fiscal year at the time the application is filed; the financial statements or the consolidated financial statements for the three most recent years, and